Investment case
Lifecore Biomedical, Inc.
LFCR · 2 developments mapped · last assessed 2026-09-28
Market Ontology has mapped 2 macro, policy, and market developments to Lifecore Biomedical, Inc. since 2026-09-28. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for LFCR yet, so no modelled value is shown. The LFCR valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run LFCR on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Webster Equity Partners to Acquire Lifecore Biomedical, Inc. ($664M)
Direct acquisition premium and certainty of transaction close.
· Moves equity value per share, liquidity premium
- Main threat
Webster Equity Partners to Acquire Lifecore Biomedical, Inc. ($664M)
Delisting from public exchange upon completion of acquisition.
· Moves public listing status
What changed, by assumption
- 2026-09-28Webster Equity Partners to Acquire Lifecore Biomedical, Inc. ($664M)
- 2026-09-28Webster Equity Partners to Acquire Lifecore Biomedical, Inc. ($664M)
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-09-29 | Valuation multiple | Bullish | Target re-rates to bid premium until close. | 0.70 |
| 2026-08-05 | Margin | Bullish | Company targeting Adjusted EBITDA margins exceeding 25% by the end of 2029 driven by cost reductions and productivity improvements. | 0.85 |
| 2026-07-03 | Net debt | Bearish | Liability-management transactions often reduce gross debt or push maturities out. | 0.70 |
| 2026-07-03 | Interest expense | Bearish | Tender/exchange extends maturity profile and typically lowers near-term interest expense. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-28 | Webster Equity Partners to Acquire Lifecore Biomedical, Inc. ($664M) | Bullish | 1-5d | 0.90 |
| 2026-09-28 | Webster Equity Partners to Acquire Lifecore Biomedical, Inc. ($664M) | Bearish | 3-12m | 0.80 |